BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16166850)

  • 1. Incidental detection of bilateral elastofibroma dorsi with F-18 FDG PET/CT.
    Wasyliw CW; Caride VJ
    Clin Nucl Med; 2005 Oct; 30(10):700-1. PubMed ID: 16166850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET/CT imaging of elastofibroma dorsi.
    Onishi Y; Kitajima K; Senda M; Sakamoto S; Suzuki K; Maeda T; Yoshikawa T; Ohno Y; Sugimura K
    Skeletal Radiol; 2011 Jul; 40(7):849-53. PubMed ID: 20978756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elastofibroma dorsi incidentally detected by (18)F-FDG PET/CT imaging.
    Erhamamci S; Reyhan M; Nursal GN; Torun N; Yapar AF; Findikcioglu A; Canpolat T
    Ann Nucl Med; 2015 Jun; 29(5):420-5. PubMed ID: 25666569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Elastofibroma Dorsi with (18)FDG PET/CT: a retrospective study.
    Blumenkrantz Y; Bruno GL; González CJ; Namías M; Osorio AR; Parma P
    Rev Esp Med Nucl; 2011; 30(6):342-5. PubMed ID: 21466907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental detection of elastofibroma dorsi on PET-CT: initial findings and changes in tumor size and standardized uptake value on serial scans.
    Davidson T; Goshen E; Eshed I; Goldstein J; Chikman B; Ben-Haim S
    Nucl Med Commun; 2016 Aug; 37(8):837-42. PubMed ID: 27092663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of elastofibroma dorsi on PET/CT imaging with (18)F-FDG.
    Fang N; Wang YL; Zeng L; Wu ZJ; Cui XJ; Wang Q; Gao S; Ding W
    Clin Imaging; 2016; 40(1):110-3. PubMed ID: 26432711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
    Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
    Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased F-18 FDG uptake on positron emission tomography/computed tomography imaging caused by plantar fibromatosis.
    Scheler J; Rehani B; Percy T; Pelstring R; Bharija A; Ames D; Mantil J
    Clin Nucl Med; 2008 Apr; 33(4):280-1. PubMed ID: 18356670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Xu R; Kido S; Suga K; Hirano Y; Tachibana R; Muramatsu K; Chagawa K; Tanaka S
    Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-18 FDG uptake associated with Elastofibroma dorsi.
    Patrikeos A; Breidahl W; Robins P
    Clin Nucl Med; 2005 Sep; 30(9):617-8. PubMed ID: 16100483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic features of elastofibroma dorsi: about 4 cases.
    Barsaoui M; Riahi H; Chelly Bouaziz M; Ladeb MF
    Tunis Med; 2018 Jan; 96(1):64-67. PubMed ID: 30324995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
    Iagaru A; Quon A; McDougall IR; Gambhir SS
    Clin Nucl Med; 2006 Dec; 31(12):754-60. PubMed ID: 17117068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of soft-tissue lesions with (18)F-FDG PET/CT: initial results of a prospective trial.
    Leal AL; Etchebehere M; Santos AO; Kalaf G; Pacheco EB; Amstalden EM; Etchebehere EC
    Nucl Med Commun; 2014 Mar; 35(3):252-9. PubMed ID: 24300379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT.
    Jiang L; Gao Y; Sheng S; Xu M; Lu L; Lu H
    Hell J Nucl Med; 2011; 14(3):316-7. PubMed ID: 22087459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
    Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
    Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
    von Falck C; Rosenthal H; Gratz KF; Galanski M
    Clin Nucl Med; 2007 Aug; 32(8):640-2. PubMed ID: 17667441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in left thigh intramuscular myxoma.
    Ho L; Wassef H; Henderson R; Seto J
    Clin Nucl Med; 2009 Apr; 34(4):224-5. PubMed ID: 19300052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.